BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 26052845)

  • 21. How health technology assessment agencies address the issue of unpublished data.
    Kreis J; Panteli D; Busse R
    Int J Technol Assess Health Care; 2014 Jan; 30(1):34-43. PubMed ID: 24622603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of HTA reports on health policy: a systematic review.
    Gerhardus A; Dintsios CM
    GMS Health Technol Assess; 2005 Nov; 1():Doc02. PubMed ID: 21289923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. "It all depends": conceptualizing public involvement in the context of health technology assessment agencies.
    Gauvin FP; Abelson J; Giacomini M; Eyles J; Lavis JN
    Soc Sci Med; 2010 May; 70(10):1518-26. PubMed ID: 20207061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. International comparison and review of a health technology assessment skills program.
    Wanke MI; Juzwishin D
    Int J Technol Assess Health Care; 2005; 21(2):253-62. PubMed ID: 15921067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of Recommendations and Use of Cardiovascular Risk Equations by Health Technology Assessment Agencies and Clinical Guidelines.
    Betts MB; Milev S; Hoog M; Jung H; Milenković D; Qian Y; Tai MH; Kutikova L; Villa G; Edwards C
    Value Health; 2019 Feb; 22(2):210-219. PubMed ID: 30711066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methods, procedures, and contextual characteristics of health technology assessment and health policy decision making: comparison of health technology assessment agencies in Germany, United Kingdom, France, and Sweden.
    Schwarzer R; Siebert U
    Int J Technol Assess Health Care; 2009 Jul; 25(3):305-14. PubMed ID: 19619349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Redefining health technology assessment in Canada: diversification of products and contextualization of findings.
    Lehoux P; Tailliez S; Denis JL; Hivon M
    Int J Technol Assess Health Care; 2004; 20(3):325-36. PubMed ID: 15446762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Experiences with and impact of health technology assessment on the German Standing Committee of physicians and patients].
    Gibis B; Rheinberger P
    Z Arztl Fortbild Qualitatssich; 2002 Feb; 96(2):82-90. PubMed ID: 11921610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CONSIDERING EQUITY IN HEALTH TECHNOLOGY ASSESSMENT: AN EXPLORATORY ANALYSIS OF AGENCY PRACTICES.
    Panteli D; Kreis J; Busse R
    Int J Technol Assess Health Care; 2015 Jan; 31(5):314-23. PubMed ID: 26711222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nature and reporting characteristics of UK health technology assessment systematic reviews.
    Carroll C; Kaltenthaler E
    BMC Med Res Methodol; 2018 May; 18(1):35. PubMed ID: 29739352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a framework and decision tool for the evaluation of health technologies based on surrogate endpoint evidence.
    Ciani O; Grigore B; Taylor RS
    Health Econ; 2022 Sep; 31 Suppl 1(Suppl 1):44-72. PubMed ID: 35608044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Developing Health Technology Assessment to address health care system needs.
    Velasco Garrido M; Gerhardus A; Røttingen JA; Busse R
    Health Policy; 2010 Mar; 94(3):196-202. PubMed ID: 19889471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diffusion and use of health technology assessment in policy making: what lessons for decentralised healthcare systems?
    Ciani O; Tarricone R; Torbica A
    Health Policy; 2012 Dec; 108(2-3):194-202. PubMed ID: 23093020
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HTA Training for Healthcare Professionals: International Overview of Initiatives Provided by HTA Agencies and Organizations.
    Hoxhaj I; Castagna C; Calabrò GE; Boccia S
    Front Public Health; 2022; 10():795763. PubMed ID: 35223734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of health technology assessment in China: New challenges.
    Chen Y; He Y; Chi X; Wei Y; Shi L
    Biosci Trends; 2018; 12(2):102-108. PubMed ID: 29760354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identifying the Need for Good Practices in Health Technology Assessment: Summary of the ISPOR HTA Council Working Group Report on Good Practices in HTA.
    Kristensen FB; Husereau D; Huić M; Drummond M; Berger ML; Bond K; Augustovski F; Booth A; Bridges JFP; Grimshaw J; IJzerman MJ; Jonsson E; Ollendorf DA; Rüther A; Siebert U; Sharma J; Wailoo A
    Value Health; 2019 Jan; 22(1):13-20. PubMed ID: 30661627
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Key Recommendations from the MedtecHTA Project.
    Tarricone R; Torbica A; Drummond M;
    Health Econ; 2017 Feb; 26 Suppl 1():145-152. PubMed ID: 28139086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overview of reviews in child health: evidence synthesis and the knowledge base for a specific population.
    Thomson D; Foisy M; Oleszczuk M; Wingert A; Chisholm A; Hartling L
    Evid Based Child Health; 2013 Jan; 8(1):3-10. PubMed ID: 23878121
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Key principles for the improved conduct of health technology assessments for resource allocation decisions.
    Drummond MF; Schwartz JS; Jönsson B; Luce BR; Neumann PJ; Siebert U; Sullivan SD
    Int J Technol Assess Health Care; 2008; 24(3):244-58; discussion 362-8. PubMed ID: 18601792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Historical development of health technology assessment in Thailand.
    Teerawattananon Y; Tantivess S; Yothasamut J; Kingkaew P; Chaisiri K
    Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():241-52. PubMed ID: 19527543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.